Document 0099 DOCN M95B0099 TI Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity. DT 9511 AU Opstad NL; Daley CL; Thurn JR; Rubins JB; Merrifield C; Hopewell PC; Janoff EN; Department of Medicine, VA Medical Center, University of; Minnesota School of Medicine, Minneapolis, MN 55417, USA. SO J Infect Dis. 1995 Aug;172(2):566-70. Unique Identifier : AIDSLINE MED/95348564 AB To determine whether defects in mucosal immunity were associated with invasive disease caused by a mucosal pathogen, Streptococcus pneumoniae, levels of salivary immunoglobulins and nonspecific immune factors were compared in subjects with human immunodeficiency virus type 1 (HIV-1) infection and in HIV-1-seronegative subjects with and without pneumococcal bacteremia. The IgA2 subclass may be of particular importance because S. pneumoniae produces IgA1 protease, which cleaves IgA1 but not IgA2. Levels (37-56 micrograms/mL) and proportions (11%-17%) of IgA2 were similar among groups. Serotype-specific capsular salivary IgA was present in a minority of patients with acute bacteremia. Levels of lactoferrin were increased with bacteremia. Neither selective mucosal IgA2 deficiency nor impaired nonspecific upper respiratory mucosal responses were associated with invasive pneumococcal disease during HIV-1 infection; thus, other defects in mucosal cellular responses and systemic immunity may predispose HIV-1-infected patients to invasive pneumococcal disease. DE Adolescence Adult AIDS-Related Opportunistic Infections/COMPLICATIONS/IMMUNOLOGY Bacteremia/COMPLICATIONS/*IMMUNOLOGY Case-Control Studies Female Human HIV Seronegativity/IMMUNOLOGY HIV Seropositivity/COMPLICATIONS/*IMMUNOLOGY HIV-1/IMMUNOLOGY Male Middle Age Mouth Mucosa/*IMMUNOLOGY Pneumococcal Infections/COMPLICATIONS/*IMMUNOLOGY Prospective Studies Saliva/IMMUNOLOGY Salivary Glands/IMMUNOLOGY Support, U.S. Gov't, Non-P.H.S. Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).